Last reviewed · How we verify
NCT06197464
FLOAT Through Anxiety: Virtual Reality Application's Efficacy as a Tool to Distract From Negative Emotions and Thoughts
NA trial testing psychoeducation on emotional regulation and distraction strategy in Control in 62 participants. Completed in 20 January 2024.
10 April 2023
Quick facts
| Lead sponsor | University of Haifa |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 62 |
| Start date | 12 March 2023 |
| Primary completion | 10 April 2023 |
| Estimated completion | 20 January 2024 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- psychoeducation on emotional regulation and distraction strategy
- Using the FLOAT app on a virtual reality device
- psychoeducation on emotional regulation and distraction strategy + Application
Conditions studied
- Control — all drugs for Control →
- Experimental — all drugs for Experimental →
Sponsor
University of Haifa
Who can join
Adults 18 to 40, any sex, with Control or Experimental. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to examine the effectiveness and safety of the VR FLOAT application as a tool to reduce negative thoughts and feelings and anxiety symptoms in students with high levels of stress and anxiety. The main questions it aims to answer are: 1. Will subjects with high levels of anxiety who will use the FLOAT application experience a more significant relief in feelings of anxiety compared to subjects in the control group? 2. Will subjects who are used to using technology find greater comfort in using VR compared to subjects who are not used to it? 3. What is the degree of satisfaction with the use of VR and are there any reports of side effects?Participants will \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets Researchers will compare control group to see The comparison between using FLOAT as a regulation strategy after psychoeducation on emotional regulation and cognitive-behavioral use of a regulation strategy after the same psychoeducation
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06197464
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Control
Currently open trials in the same condition.
- NCT06750107 — Testing the Efficacy of Safe South Africa · Phase 3 · active not recruiting
- NCT06116292 — Impact of the Implementation of a Telemedicine Program on Patients Diagnosed with Asthma · NA · recruiting
- NCT06169540 — Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF) · recruiting
- NCT05517811 — Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection · recruiting
Other University of Haifa trials
Trials by the same sponsor.
- NCT07379801 — The Musculoskeletal System During Puberty in Dancers With Scoliosis, and the Effect of an Exercise Program · NA · recruiting
- NCT07325929 — Online Radical Acceptance Intervention for Social Anxiety Disorder · NA · not yet recruiting
- NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
- NCT07367763 — The Relationship Between Self-Awareness and Risk of Falls During Walking in Adults · active not recruiting
- NCT06932679 — Perception of Affordances and Obstacle Crossing in People With Parkinson's Disease and Healthy Adults · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06197464 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Haifa
- Last refreshed: 17 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06197464.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing